The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
114962993 11496299 3 F 2011 20160802 20150911 20160816 EXP FR-JAZZ-2011-281 JAZZ STAQUET H, DUPOIRON D, NADER E, MENEI P.. INTRACEREBROVENTRICULAR PAIN TREATMENT WITH ANALGESIC MIXTURES INCLUDING ZICONOTIDE FOR INTRACTABLE PAIN. PAIN PHYSICIAN. 2016;19:E905-E915 65.24 YR M Y 78.00000 KG 20160816 MD FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
114962993 11496299 1 PS PRIALT ZICONOTIDE ACETATE 1 0.02 ?G, QH 18 UG Y 21060 .02 UG
114962993 11496299 2 SS PRIALT ZICONOTIDE ACETATE 1 Intrathecal 0.04 UG, ONCE/HOUR 18 UG Y 21060 .025 UG
114962993 11496299 3 SS PRIALT ZICONOTIDE ACETATE 1 Intrathecal 0.04 UG, ONCE/HOUR 18 UG Y 21060 .04 UG
114962993 11496299 4 SS PRIALT ZICONOTIDE ACETATE 1 Intrathecal 0.04 UG, ONCE/HOUR 18 UG Y 21060 .02 UG
114962993 11496299 5 SS MORPHINE SULFATE. MORPHINE SULFATE 1 0.05 MG, QH 57 MG U 0 .05 MG INJECTION
114962993 11496299 6 SS MORPHINE SULFATE. MORPHINE SULFATE 1 0.088 MG, QH 57 MG U 0 .088 MG INJECTION
114962993 11496299 7 SS MORPHINE SULFATE. MORPHINE SULFATE 1 0.148 MG, QH 57 MG U 0 .148 MG INJECTION
114962993 11496299 8 SS MORPHINE SULFATE. MORPHINE SULFATE 1 0.18 MG, QH 57 MG U 0 .18 MG INJECTION
114962993 11496299 9 SS MORPHINE SULFATE. MORPHINE SULFATE 1 0.188 MG, QH 57 MG U 0 .188 MG INJECTION
114962993 11496299 10 SS Naropeine ROPIVACAINE HYDROCHLORIDE 1 UNK MG, ONCE/HOUR U 0 .08 MG INJECTION
114962993 11496299 11 SS Naropeine ROPIVACAINE HYDROCHLORIDE 1 UNK MG, ONCE/HOUR U 0 .09 MG INJECTION
114962993 11496299 12 C MORPHINE SULFATE. MORPHINE SULFATE 1 Oral UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
114962993 11496299 1 Neuralgia
114962993 11496299 2 Pain
114962993 11496299 5 Neuralgia
114962993 11496299 6 Pain
114962993 11496299 10 Neuralgia
114962993 11496299 11 Pain

Outcome of event

Event ID CASEID OUTC COD
114962993 11496299 DE
114962993 11496299 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
114962993 11496299 Agitation
114962993 11496299 Aphasia
114962993 11496299 Arterial haemorrhage
114962993 11496299 Confusional state
114962993 11496299 Hostility
114962993 11496299 Incorrect route of drug administration
114962993 11496299 Nausea
114962993 11496299 Neoplasm progression
114962993 11496299 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
114962993 11496299 1 20110401 20110404 0
114962993 11496299 2 20110405 20110407 0
114962993 11496299 3 20110408 20110418 0
114962993 11496299 4 20110419 20110429 0
114962993 11496299 5 20110401 20110404 0
114962993 11496299 6 20110405 20110407 0
114962993 11496299 7 20110408 20110410 0
114962993 11496299 8 20110411 20110418 0
114962993 11496299 9 20110419 201105 0
114962993 11496299 10 20110418 0
114962993 11496299 11 201105 0